Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-015445
Filing Date
2008-03-14
Accepted
2008-03-14 16:46:53
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 v107013_10k.htm 10-K 1993512
2 GRAPHIC graph.jpg GRAPHIC 26135
3 v107013_ex4-1.htm EX-4.1 1520
4 GRAPHIC specimenx1x1.jpg GRAPHIC 117346
5 GRAPHIC specimenx1x2.jpg GRAPHIC 80841
6 v107013_ex10-28.htm EX-10.28 77166
7 v107013_ex23-1.htm EX-23.1 5944
8 v107013_ex31-1.htm EX-31.1 12002
9 v107013_ex31-2.htm EX-31.2 11645
10 v107013_ex32-1.htm EX-32.1 7761
11 v107013_ex32-2.htm EX-32.2 7779
  Complete submission text file 0001144204-08-015445.txt   2428354
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Filer) CIK: 0001144062 (see all company filings)

EIN.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-32947 | Film No.: 08690019
SIC: 2834 Pharmaceutical Preparations